+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Vascular Grafts - Global Market Trajectory & Analytics

  • ID: 4806364
  • Report
  • February 2022
  • Region: Global
  • 481 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Cook Medical
  • CryoLife, Inc.
  • ENDOLOGIX LLC.

Global Vascular Grafts Market to Reach US$4.4 Billion by the Year 2026


Vascular grafts are implants that are used during surgical procedures that involve peripheral vessel bypass or aortic repair. They are synthetic tubes that are surgically implanted in the arteries and veins to repair diseased or injured areas in the arteries. Vascular grafts are also used to patch up whole segments of the aorta and other larger arteries. By harnessing the vascular grafts, damaged or diseased blood vessels are replaced or patched up to redirect the blood flow. Vascular grafts come in an array of materials, such as biosynthetic, polyester, polyurethane, and polytetrafluoroethylene (ePTFE). While vascular grafts are largely used in the heart during a coronary artery bypass, they are also deployed to treat renal failure, vascular occlusion, vascular disease, and aneurysm. The increasing prevalence of diabetes, hypertension, vascular occlusions, end-stage renal disease, and peripheral artery diseases has been a growth driver for the vascular graft treatment market. There is greater public awareness of coronary diseases brought about by sedentary lifestyles, unhealthy eating habits, and smoking. Vascular grafts are also deployed for kidney transplants for repairing renal vessels.

Amid the COVID-19 crisis, the global market for Vascular Grafts estimated at US$3.1 Billion in the year 2020, is projected to reach a revised size of US$4.4 Billion by 2026, growing at a CAGR of 6.4% over the analysis period. Endovascular Aneurysm Repair (EVAR), one of the segments analyzed in the report, is projected to grow at a 6.2% CAGR to reach US$2.1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Peripheral Vascular Repair segment is readjusted to a revised 8% CAGR for the next 7-year period. This segment currently accounts for a 32.7% share of the global Vascular Grafts market. The endovascular grafts dominated market share, fueled by the surging demand for sophisticated endovascular grafts. Anaconda AAA Stent Graft System of Terumo and Endurant II AAA Stent Graft System of Medtronic are the main products in the market. Increasing R&D and new product introductions are expected to foster market growth.



The U.S. Market is Estimated at $1.3 Billion in 2021, While China is Forecast to Reach $486.7 Million by 2026


The Vascular Grafts market in the U.S. is estimated at US$1.3 Billion in the year 2021. The country currently accounts for a 40.2% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$486.7 Million in the year 2026 trailing a CAGR of 8.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR while Rest of European market (as defined in the study) will reach US$213.4 Million by the end of the analysis period.

Hemodialysis Access Segment to Reach $876 Million by 2026


The hemodialysis vascular graft market has been registering healthy demand, attributed to the growing prevalence of kidney diseases worldwide. Further, the rising use of biological access products on account of technological developments is also driving market growth. Rising number of patients with renal impairment and low availability of kidney donors are encouraging hemodialysis procedures in such patients, which is boosting market prospects. In the global Hemodialysis Access segment, USA, Canada, Japan, China and Europe will drive the 4.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$590.8 Million in the year 2020 will reach a projected size of US$793.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$68.9 Million by the year 2026, while Latin America will expand at a 4.9% CAGR through the analysis period.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Bard Peripheral Vascular Inc.
  • Cardinal Health, Inc.
  • Cook Medical
  • CryoLife, Inc.
  • ENDOLOGIX LLC.
  • Getinge AB
  • W. L. Gore & Associates, Inc.
  • LeMaitre Vascular, Inc.
  • Medtronic plc
  • Terumo Corporation
Frequently Asked Questions about the Global Market for Vascular Grafts

What is the estimated value of the Global Market for Vascular Grafts?

The Global Market for Vascular Grafts was estimated to be valued at $3.1 Billion in 2020.

What is the growth rate of the Global Market for Vascular Grafts?

The growth rate of the Global Market for Vascular Grafts is 6.0%, with an estimated value of $4.4 Billion by 2026.

What is the forecasted size of the Global Market for Vascular Grafts?

The Global Market for Vascular Grafts is estimated to be worth $4.4 Billion by 2026.

Who are the key companies in the Global Market for Vascular Grafts?

Key companies in the Global Market for Vascular Grafts include Abbott Laboratories, B. Braun Melsungen AG, Bard Peripheral Vascular Inc., Cardinal Health, Inc., Cook Medical, CryoLife, Inc., ENDOLOGIX LLC., Getinge AB and LeMaitre Vascular, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Cook Medical
  • CryoLife, Inc.
  • ENDOLOGIX LLC.

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Vascular Grafts – Global Key Competitors Percentage Market Share in 2022 (E)
  • A Prelude to Vascular Grafting
  • Impact of Covid-19 and a Looming Global Recession
  • 2020 Marked as a Year of Disruption & Transformation
  • COVID-19 and Vascular Grafts Market
  • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • Impact of COVID-19 Outbreak on Elective Surgeries
  • Global Market Prospects and Overview
  • Vascular Grafts Market Set for a Rapid Growth
  • Endovascular Stent-Grafts Account for Larger Share
  • Competition
  • Recent Market Activity
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Increasing Incidence of Cardio Vascular Disease Bodes Well for the Global Vascular Graft Market
  • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
  • Rising Preference for Minimally Invasive Procedures Boosts Market Prospects
  • Rising Prevalence of Kidney Diseases Drives the Global Hemodialysis Vascular Graft Market
  • Hemodialysis Remains the Major Modality for Dialysis Treatment - A Key Opportunity
  • Global Dialysis Patient Population Distribution by Modality for Select Countries (2020): Percentage Breakdown of Hemodialysis (HD) and Peritoneal Dialysis (PD) Patients
  • Global Population of ESRD Patients Undergoing Therapy by Type of Treatment (2020): Percentage Breakdown of Patients Receiving Hemodialysis, Kidney Transplants, and Peritoneal Dialysis
  • Home Hemodialysis: A Niche Albeit High Potential Market
  • World Dialysis Clinics Market by Region (2019): Percentage Breakdown of Patients Treated by Type of Operator
  • Global Dialysis Market by Region: Percentage Breakdown of Patients Receiving Dialysis Treatment in In-Centre and Home Settings for 2019
  • Aging Population Drives Demand for Vascular Grafts
  • Increasing Healthcare Expenditure to Foster Growth
  • World Healthcare Expenditure (In US$ Trillion) for the Years 2016 & 2018
  • Rising Middle Class Population Aids Growth
  • Global Middle Class Population (in Millions) and as a Percentage of Total Population: 2005, 2015, 2025 & 2035
  • Global Middle Class Spending (in US$ Trillion) by Geographic Region
  • Risk of CAD in Obesity Offers Prospects for Coronary Stenting
  • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
  • Cell-Free Tissue Engineered Vascular Grafts Aid in Vascular Remodeling
  • Cells for Cells Develops VEINTIS™
  • New Approach for Optimizing TEVGs
  • 3D Printed Vascular Scaffolds Hold Potential to be the New-Age TEVGs
  • A Review of Select Vascular Developments
  • Some of the important vascular innovations expected in the near-term include:
  • Offerings of Moving Analytics and Vasctrac

4. GLOBAL MARKET PERSPECTIVE


III. MARKET ANALYSIS

UNITED STATES

  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)

CANADA

JAPAN

  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)

CHINA

  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)

EUROPE

  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)

FRANCE

  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)

GERMANY

  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)

ITALY

UNITED KINGDOM

  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)

SPAIN


RUSSIA


REST OF EUROPE

ASIA-PACIFIC

  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)

AUSTRALIA

  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)

INDIA

  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)

SOUTH KOREA


REST OF ASIA-PACIFIC

LATIN AMERICA

  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)

ARGENTINA


BRAZIL


MEXICO


REST OF LATIN AMERICA

MIDDLE EAST

  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)

IRAN


ISRAEL


SAUDI ARABIA


UNITED ARAB EMIRATES


REST OF MIDDLE EAST

AFRICA

  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)

IV. COMPETITION

  • Total Companies Profiled: 44
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Bard Peripheral Vascular Inc.
  • Cardinal Health, Inc.
  • Cook Medical
  • CryoLife, Inc.
  • ENDOLOGIX LLC.
  • Getinge AB
  • W. L. Gore & Associates, Inc.
  • LeMaitre Vascular, Inc.
  • Medtronic plc
  • Terumo Corporation
Note: Product cover images may vary from those shown